Liquid antibacterial preparation for oral use

Ingredients (1 liter):

Ciprofloxacin — 50 gr

Gentamicin — 25 gr

Indications:

Pigs for therapeutic purposes and broiler chickens, replacement chicks, breeding poultry with medical and preventive purposes with infectious diseases of the gastrointestinal tract, respiratory tract, urogenital system, salmonellosis, streptococcosis, necrotic enteritis, dysentery in pigs, atrophic rhinitis, gemofileze, mycoplasmosis, with mixed infections, secondary infections in viral diseases and other diseases, pathogens which are sensitive to fluoroquinolones and aminoglycosides, including: Escherihia coli, Salmonella sp., Pasteurella sp., Staphylococcus sp., Streptococcus sp., Klebsiella spp., Bordetella bronchiseptica, Corynebacterium pyogenes, Pseudomonas aeruginosa, Campylobacter spp., Enterobacter spp., Erysipelothrix spp., Proteus spp., Brucella canis, Actinobacillus spp., Listeria monocytogenes, Haemophilus spp., Clostridium spp., Neisseria, Serratia marcescens, Shigella spp., Serpulina (Treponema) hyodysenteriae, Bacillus spp., and Mycoplasma spp..

Dosage: orally with drinking water or mixed with feed

Elimination period:

Ciprofloxacin + Gentamicin = synergy action

CIPROGEN – new integrated antibacterial preparation the uniqueness of action is based on a combination of two antibacterial components: fluoroquinolone and aminoglycoside. Combination of fluoroquinolones with other antimicrobial preparations usually has an additive or indifferent effect. In the case of a combination of ciprofloxacin and gentamicin observed synergistic effect, i.e. is enhanced antimicrobial action. This is especially expressed in enhancing the bactericidal properties of ciprofloxacin. This effect is due to a similar mechanism of action of both components of the preparation, which is associated with impaired synthesis of DNA and protein, respectively, in a microbial cell. This leads to the death of the microbial cells. What is important, it is not destroyed in the death of the bacterial cell itself. As a consequence, no endotoxin released from dead bacterial cells, which, in turn, leads to serious complications, up to sepsis.

Registration number: 10-3-36.12-1299№ПВР-3-36.12/02898

To get the product, please send the request

Our contacts

Tel/fax +7 (4722) 58-57-42, 58-32-32

e-mail: sales@belfarma.com or client@belfarma.com